Peptide Cancer Vaccine Market Forecast Indicates Significant Opportunities by 2030
The global peptide cancer vaccine market is experiencing substantial growth due to the increasing prevalence of cancer, rising investments in immunotherapy research, and advancements in precision medicine. The market was valued at USD 1,850.30 million in 2024 and is projected to grow from USD 2,274.13 million in 2025 to USD 11,737.11 million by 2032, exhibiting a remarkable CAGR of 26.42%...
0 Комментарии 0 Поделились 141 Просмотры 0 предпросмотр
Спонсоры
Myliveroom — Live Events & Online Communities https://myliveroom.com